Restoration by intratracheal gene transfer of bicarbonate secretion in cystic fibrosis mouse gallbladder.

Gallbladders from cystic fibrosis (CF) mice ( Cftrtm1Cam and Cftrtm2Cam ) were examined with the short-circuit current technique. The tissues failed to show any electrogenic anion transport in response to forskolin (cAMP stimulus) but responded to the Ca2+ ionophore ionomycin. Administration of the plasmid pTrial10-CFTR2 complexed with cationic liposomes {3β-[ N-(dimethylaminoethane)-carbamoyl]cholesterol andl-α-phosphatidylethanolamine dioleolyl} to the airways restored the phenotype of CF gallbladders to that of the wild type, but did not do so when given orally. Formation of human CFTR mRNA in gallbladders of transfected CF null mice was demonstrated. Using the reporter genes pCMV- luc and pCMV- LacZ, we showed that 1) the intratracheal route was more effective than the oral, intravenous, intramuscular, subcutaneous, or intraperitoneal routes in expressing luciferase activity in the gallbladder and 2) β-galactosidase staining after pCMV- LacZ was confined to the columnar epithelium lining the gallbladder without any discernible activity in its smooth muscle. The discovery of an unusual route for gene transfer to the biliary system may give useful insight into counteracting the consequences of biliary fibrosis in human CF patients.

[1]  A. Cuthbert,et al.  Electrogenic bicarbonate secretion in mouse gallbladder. , 1998, American journal of physiology. Gastrointestinal and liver physiology.

[2]  J. Isner,et al.  Histochemical staining following LacZ gene transfer underestimates transfection efficiency. , 1997, Human gene therapy.

[3]  M. Evans,et al.  Chloride secretion in the trachea of null cystic fibrosis mice: the effects of transfection with pTrial10‐CFTR2. , 1997, The Journal of physiology.

[4]  M. Evans,et al.  Cystic fibrosis transmembrane conductance regulator mediates the cyclic adenosine monophosphate‐induced fluid secretion but not the inhibition of resorption in mouse gallbladder epithelium , 1997, Hepatology.

[5]  J. Scoazec,et al.  Expression of cystic fibrosis transmembrane conductance regulator in human gallbladder epithelial cells. , 1995, Laboratory investigation; a journal of technical methods and pathology.

[6]  H. Morreau,et al.  A mouse model for the cystic fibrosis delta F508 mutation. , 1995, The EMBO journal.

[7]  E. Marshall Gene therapy's growing pains , 1995, Science.

[8]  B. Abella,et al.  Generation and characterization of a ΔF508 cystic fibrosis mouse model , 1995, Nature Genetics.

[9]  R. Perrone,et al.  Correction of the cystic fibrosis defect by gene complementation in human intrahepatic biliary epithelial cell lines. , 1995, Gastroenterology.

[10]  F. Collins,et al.  Localization of the cystic fibrosis transmembrane conductance regulator in human bile duct epithelial cells. , 1993, Gastroenterology.

[11]  J. Wilson,et al.  An approach for treating the hepatobiliary disease of cystic fibrosis by somatic gene transfer. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[12]  M. Evans,et al.  Production of a severe cystic fibrosis mutation in mice by gene targeting , 1993, Nature Genetics.

[13]  Wendy L. Kimber,et al.  Cystic fibrosis in the mouse by targeted insertional mutagenesis , 1992, Nature.

[14]  M. Welsh,et al.  cAMP stimulates bicarbonate secretion across normal, but not cystic fibrosis airway epithelia. , 1992, The Journal of clinical investigation.

[15]  C. Pollard,et al.  Anion selectivity and block of the small-conductance chloride channel on pancreatic duct cells. , 1990, The American journal of physiology.

[16]  E. Schwiebert,et al.  Chloride channels in the apical membrane of cortical collecting duct cells. , 1990, The American journal of physiology.

[17]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.